Previous close | 1.2000 |
Open | 1.2000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 195.00 |
Expiry date | 2024-05-17 |
Day's range | 1.2000 - 1.2000 |
Contract range | N/A |
Volume | |
Open interest | 150 |
Unraveling the Financial and Strategic Position of ALNY in the Biopharmaceutical Arena
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Alnylam (ALNY) delivered earnings and revenue surprises of 78.67% and 17.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?